Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Cardiovascular Abnormalities
Trial Information
A Study of Self Management and Self Testing in Patients With Heart Valve Replacement.
Status: Recruiting
Protocol Number: TELEQIN 10/03
Sponsor:
Company Division: Diagnostic
Official Scientific Title: TELEQIN
Brief Summary: This study will compare the effect of patient self-management, and patient self-testing plus telemetry, on the bleeding rate in patients with mechanical heart valve replacement. It will evaluate the telemedicine tool for patients who are not able to perform self-management.
Study Phase: N/A
Study Design / Study Details:
- Purpose:
- Allocation: Randomized
- Masking: Open Label
- Control: Active
- Assignment: Parallel
- Endpoints:
Study Type:
Interventional
Condition: Cardiovascular Abnormalities
Intervention Type: Diagnostic Test
Intervention Name: Set CoaguChek XS Systemasche
Primary Outcome:
Key Secondary Outcomes:
Inclusion Criteria:
- adult patients, >=18 years of age;
- mechanical aortic, mitral or double valve replacement.
Exclusion Criteria:
- chronic gastrointestinal ulceration;
- incompatibility to anticoagulants.
Gender: Males or Females
Age Limits: Min: 18 Years Max: 99 Years
Accepts Healthy Volunteers: No
Anticipated Start Date: March, 2004
Trial Registration Date: 12/05/2006
Date Last Updated: 12/14/2006
Link To Trial Results
E-mail: genentechclinicaltrials@druginfo.com
Research Site:
Located In:
Düsseldorf 40225
Germany
Phone: 888-662-6728 (U.S. Only)
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
